Strategies For Ovulation Induction In The Management Of Anovulatory Polycystic Ovary Syndrome
Published 2007 · Medicine
Download PDFAnalyze on Scholarcy
This paper references
A Comparison of In Vitro Maturation and In Vitro Fertilization for Women With Polycystic Ovaries
T. Child (2002)
CLASSIFICATION OF AMENORRHOEIC STATES AND THEIR TREATMENT BY OVULATION INDUCTION
B. Lunenfeld (1974)
Body mass index and ovulatory infertility.
F. Grodstein (1994)
Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial
N. Bayram (2004)
Aromatase inhibitors in ovulation induction.
M. F. Mitwally (2004)
Polycystic ovaries treated by laparoscopic laser vaporization.
J. Daniell (1989)
Maternal Morbid Obesity and the Risk of Adverse Pregnancy Outcome
M. Cedergren (2004)
Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.
P. A. Radon (1999)
HORMONAL PROFILES FOLLOWING CLOMIPHENE CITRATE THERAPY IN CONCEPTION AND NONCONCEPTION CYCLES
ZEEV SHOHAM (SCHWARTZ) (1990)
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
D. Hamilton‐Fairley (1992)
The use of metformin for women with PCOS undergoing IVF treatment.
T. Tang (2006)
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
A. Balen (1995)
Modern use of clomiphene citrate in induction of ovulation.
E. Kousta (1997)
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.
J. Nestler (1998)
Meta-analysis of recombinant versus urinary-derived FSH: an update.
H. Al-Inany (2003)
Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women.
A. Clark (1995)
Confidential Enquiry into Maternal and Child Health
A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
M. Costello (2003)
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.
R. Agrawal (1998)
Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial
Etelka Moll (2006)
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
R. Azziz (2001)
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome
J. O. E. N. Estler (1999)
In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome.
R. Homburg (1993)
Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
G. Maciel (2004)
The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
B. Fauser (1993)
Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage
A. Balen (1993)
Female infertility: Treatment options for complicated cases
K. Diedrich (1997)
Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope.
H. Gjönnaess (1984)
Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
J. Lord (2003)
Fat and female fecundity: prospective study of effect of body fat distribution on conception rates.
B. M. Zaadstra (1993)
Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.
R. Fleming (2002)
A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
M. Macdougall (1993)
Insulin resistance and the polycystic ovary syndrome
Hao Gui-qin (2005)
A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome.
A. Balen (1994)
Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.
A. Balen (1994)
FACTORS INVOLVED IN THE INDUCTION OF FERTILE OVULATION WITH HUMAN GONADOTROPHINS
J. Brown (1969)
Effects of obesity on women's reproduction and complications during pregnancy.
Y. Linné (2004)
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.
S. Palomba (2004)
Should obese women with polycystic ovary syndrome receive treatment for infertility?
A. Balen (2006)
Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.
D. White (1996)
Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome.
N. A. Armar (1990)
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
D. Kiddy (1992)
Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome.
D. Hamilton‐Fairley (1991)
Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment.
A. Clark (1998)
This paper is referenced by
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
M. Jensterle (2008)
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome.
M. Jensterle (2008)
Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial
Mohamad E. Ghanem (2013)